Home  »  Financial News   »  What Do Analysts Say About Pulmonx Corporation (LU...

What Do Analysts Say About Pulmonx Corporation (LUNG)?

How have the shares performed?

Pulmonx Corporation (LUNG) saw an uptrend of 2.07% in the recent trading with $42.00 being its most recent. The current price level -39.55% lower than the highest price of $69.48 marked by the stock while trading over the past 52-weeks, whereas it is 17.29% higher than the lowest price of $35.81 the company dropped to over past 52-weeks. The latest news story on LUNG appeared in GlobeNewswire under the title “Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema” on May-17-21.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Squeezing the time span to 30 day period shows us the stock is currently trading -13.88% below one month high and is +17.29% above of the lowest during that time. Looking into the simple moving average, Pulmonx Corporation (LUNG)’s stock stands at a SMA-50 of $45.36 while that of 5-day is reading $41.43.

Do analysts rate it as a buy, sell or hold?

Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.90 for the stock.

Pulmonx Corporation Earnings – What Happened With LUNG

Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Pulmonx Corporation (LUNG) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of 10.50% for net revenue. During the reported three-month period, company’s sales were $9.24 billion while analysts on average were estimating the same to be $10.51 million.

LUNG – Pulmonx Corporation Stock Earnings Estimates

The perspective of Pulmonx Corporation (NASDAQ:LUNG)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.38 for stock’s EPS in the current quarter. 7 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.34.

Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 35.37 million. LUNG does have institutional investors; and they hold 75.70% of the stock.

Pulmonx Corporation – Insider Activity and Holdings

Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 49,428 shares. On the other hand, LUNG declared 2,055,188 shares have been sold in 19 insider transactions over the past three months.

As on Dec 30, 2020, KPCB XIII Associates, LLC was the top most holder in Pulmonx Corporation (NASDAQ:LUNG) with an ownership of 1.42 million shares of the company or 3.98% of the stake worth $98.1 million. The filing also reveals RTW Investments LP as the second largest holder in the company with a control over 3.17% of the outstanding shares. Its stake is worth $77.96 million for having 1.13 million shares in hand.

Gilder, Gagnon, Howe & Co. also came holding a key position in the company during the recent quarter and it now holds 3.09% of the outstanding shares. With this there are now 135 institutions which have possession in LUNG’s shares.

Currently, the stock has been recommended as Strong Buy by 7 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.90 for the stock.

The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, current ratio recorded by Pulmonx Corporation was 19.96 while posting a debt to equity ratio of 0.08. The count was 11.05 for long-term debt to equity ratio.

Pulmonx Corporation’s return on equity, or ROE, is -493.30%, compared to the industry average of -0.14% for Healthcare – Medical Devices. Although this indicates that LUNG fails to use its equity well, the metric will vary significantly depending on the industry.

Technical Analysis of Pulmonx Corporation (NASDAQ:LUNG) stock

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam